Medtronic has announced that it has received the European CE Mark of regulatory approval to use its deep brain stimulation therapy to control seizures in some epilepsy patients.
The implantable pacemaker-like device will be introduced to hospitals throughout Europe by the end of the year, but the U.S. timeline is unclear. The FDA is reviewing Medtronic's application to broaden use of the device, according to the report.
Read the news release on the approval of the brain device from Medtronic.
Read more coverage on orthopedic and spine devices:
- 10 Orthopedic and Spine Devices Recently Launched or Approved
- Electronic Spinal Devices to Treat Back Pain Now Used on a Wider Array of Patients
The implantable pacemaker-like device will be introduced to hospitals throughout Europe by the end of the year, but the U.S. timeline is unclear. The FDA is reviewing Medtronic's application to broaden use of the device, according to the report.
Read the news release on the approval of the brain device from Medtronic.
Read more coverage on orthopedic and spine devices:
- 10 Orthopedic and Spine Devices Recently Launched or Approved
- Electronic Spinal Devices to Treat Back Pain Now Used on a Wider Array of Patients